Test and Treat for Prediabetes: A Review of the Health Effects of Prediabetes and the Role of Screening and Prevention

被引:9
作者
Chakkalakal, Rosette J. [1 ,2 ,3 ]
Galaviz, Karla I. [4 ]
Thirunavukkarasu, Sathish [2 ,3 ]
Shah, Megha K. [2 ,3 ]
Narayan, K. M. Venkat [3 ,5 ]
机构
[1] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA 30322 USA
[3] Emory Univ, Emory Global Diabet Res Ctr, Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA
[4] Indiana Univ, Sch Publ Hlth Bloomington, Bloomington, IN USA
[5] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA
关键词
impaired glucose tolerance; impaired fasting glucose; prediabetic state; health promotion; IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; HIGH BLOOD-PRESSURE; DIABETES PREVENTION; COST-EFFECTIVENESS; LABELING PATIENTS; AMERICAN-COLLEGE; TASK-FORCE; RISK; REGRESSION;
D O I
10.1146/annurev-publhealth-060222-023417
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The term prediabetes describes blood glucose levels above the normal range but below the threshold to diagnose type 2 diabetes. Several population health initiatives encourage a test and treat approach for prediabetes. In this approach, screening and identification of individuals with prediabetes should be followed by prompt referral to structured lifestyle modification programs or pharmacologic interventions that have been shown to prevent or delay the progression to type 2 diabetes in clinical trials. Here we provide a critical review of evidence for this test and treat approach by examining health outcomes associated with prediabetes and the availability and effectiveness of lifestyle modification approaches that target prediabetes.We also describe current limitations to the reach and uptake of evidence-based treatment options for prediabetes. Finally, we highlight lessons learned from identifying and labeling other preconditions to consider challenges and opportunities that may arise with increasing awareness of prediabetes as part of routine preventive care.
引用
收藏
页码:151 / 167
页数:17
相关论文
共 93 条
  • [1] Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
    Abdul-Ghani, MA
    Tripathy, D
    DeFronzo, RA
    [J]. DIABETES CARE, 2006, 29 (05) : 1130 - 1139
  • [2] Reach and Use of Diabetes Prevention Services in the United States, 2016-2017
    Ali, Mohammed K.
    Bullard, Kai McKeever
    Imperatore, Giuseppina
    Benoit, Stephen R.
    Rolka, Deborah B.
    Albright, Ann L.
    Gregg, Edward W.
    [J]. JAMA NETWORK OPEN, 2019, 2 (05)
  • [3] The Diabetes Prevention Gap And Opportunities To Increase Participation In Effective Interventions
    Alva, Maria L.
    Chakkalakal, Rosette J.
    Moln, Tannaz
    Galaviz, Karla, I
    [J]. HEALTH AFFAIRS, 2022, 41 (07) : 971 - 979
  • [5] 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S39 - S45
  • [6] Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study
    Anjana, R. M.
    Pradeepa, R.
    Deepa, M.
    Datta, M.
    Sudha, V.
    Unnikrishnan, R.
    Bhansali, A.
    Joshi, S. R.
    Joshi, P. P.
    Yajnik, C. S.
    Dhandhania, V. K.
    Nath, L. M.
    Das, A. K.
    Rao, P. V.
    Madhu, S. V.
    Shukla, D. K.
    Kaur, T.
    Priya, M.
    Nirmal, E.
    Parvathi, S. J.
    Subhashini, S.
    Subashini, R.
    Ali, M. K.
    Mohan, V.
    [J]. DIABETOLOGIA, 2011, 54 (12) : 3022 - 3027
  • [7] Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study
    Anjana, Ranjit Mohan
    Deepa, Mohan
    Pradeepa, Rajendra
    Mahanta, Jagadish
    Narain, Kanwar
    Das, Hiranya Kumar
    Adhikari, Prabha
    Rao, Paturi Vishnupriya
    Saboo, Banshi
    Kumar, Ajay
    Bhansali, Anil
    John, Mary
    Luaia, Rosang
    Reang, Taranga
    Ningombam, Somorjit
    Jampa, Lobsang
    Budnah, Richard O.
    Elangovan, Nirmal
    Subashini, Radhakrishnan
    Venkatesan, Ulagamathesan
    Unnikrishnan, Ranjit
    Das, Ashok Kumar
    Madhu, Sri Venkata
    Ali, Mohammed K.
    Pandey, Arvind
    Dhaliwal, Rupinder Singh
    Kaur, Tanvir
    Swaminathan, Soumya
    Mohan, Viswanathan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08) : 585 - 596
  • [8] [Anonymous], 2015, Disease Control Priorities: Vol. 3: Cancer
  • [9] [Anonymous], 2023, Breast Cancer: Screening. An Update for this Topic is in Progress
  • [10] Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force
    Balk, Ethan M.
    Earley, Amy
    Raman, Gowri
    Avendano, Esther A.
    Pittas, Anastassios G.
    Remington, Patrick L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (06) : 437 - +